chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 02-APR-2022; Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 02-APR-2022; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 02-APR-2022) and PRODUCT STORAGE ERROR (Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 02-APR-2022) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 066H21A) for COVID-19 vaccination.     No Medical History information was reported.    On 02-Apr-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 02-Apr-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 02-APR-2022). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 02-APR-2022). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 02-APR-2022) and PRODUCT STORAGE ERROR (Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 02-APR-2022) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant products were not provided.  The time of vaccine administration was reported as 10:12:06.   Treatment medications were not reported.
Almost immediate total body flushing and tingling, including numbness/tingling on left side of face.  After 10  min. shivering though not feeling cold for about 5-10 min.  Then later in afternoon continuous light numbness on left side of face.  Slight headache.  It's almost 3:00 p.m. on 3/14 and left side of face still feels somewhat numb but right side feels ok.  Smile is even both right after the injection when nurse checked and now.  Never a problem breathing.
Allergic rx noted 6/16/11. Reports 6 x 8 inch red raised area and itching. On 6/20/11 3 cm x 4.5 cm red raised area at site. No further itching.
Client received the first dose of her Pfizer COVID-19 vaccine and during the post-vaccination wait period, she complained of feeling warm, palpitations and tightness in the chest. ?911? was immediately called. She denied any itching or difficulty breathing and stated that she has a history of allergies as well as hypertension, for which she takes Lisinopril, 30mg and Lasix, 40mg. She also indicated that prior to coming in for the vaccine, she took some steroids and antihistamines at the suggestion of her primary care physician. Vital signs were as follows: BP=174/100, Pulse=111. A recheck of her BP was 200/110. The EMT ? responded to the call. They evaluated the client, treated her with an EpiPen and started an IV line. At 11:15, she was transported to the hospital.
1) sore arm: started within an hour of vaccination and continued through the following day  2) head, neck, back, and eye pain: started in the middle of the night. I awoke in pain and was unable to fall back asleep at 5:30 AM. I took 2 Advil and I cried in pain for a half hour or so. Then the eye pain subsided. I was still in sever neck, head, and back pain through 7:30 and felt okay to move around by 9:30.  This pain came back in waves throughout the day.   3) Fever:  I didn?t check my temperature till 9:30, probably should have. I had a low grade fever at that point of 99.7.   4) nausea: I was unable to eat between the hours of 11:00 and 5:00 due to nausea at the thought of food.   5) headaches and eye pain upon changing elevation: woke up the following morning (11/18) feeling much better until I stood up. I got a splitting headache. Any time I shifted from sitting or crouching to standing my head and eyes hurt very much. This has gone on for two hours despite eating and drinking
Date of Admission: 10/11/2022   Date of Discharge:Deceased on 10/22/2022   Admission Diagnosis: COVID [U07.1] Acute hypoxemic respiratory failure [J96.01]     Hospital Principal Problem (Discharge Diagnoses): Paroxysmal atrial fibrillation with RVR
Vaccine was stored in refrigerator on 04-Jun-2022 and administered vaccine on 21-Jul-2022; No adverse event; Administered the vaccine to 346 patients after the 30 day by used; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Administered the vaccine to 346 patients after the 30 day by used), PRODUCT STORAGE ERROR (Vaccine was stored in refrigerator on 04-Jun-2022 and administered vaccine on 21-Jul-2022) and NO ADVERSE EVENT (No adverse event) in a 15-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 058A22-2A) for COVID-19 prophylaxis.     No Medical History information was reported.   On 21-Jul-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 21-Jul-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Administered the vaccine to 346 patients after the 30 day by used). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vaccine was stored in refrigerator on 04-Jun-2022 and administered vaccine on 21-Jul-2022) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Administered the vaccine to 346 patients after the 30 day by used), PRODUCT STORAGE ERROR (Vaccine was stored in refrigerator on 04-Jun-2022 and administered vaccine on 21-Jul-2022) and NO ADVERSE EVENT (No adverse event) outcome was unknown.      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (Administered the vaccine to 346 patients after the 30 day by used) and PRODUCT STORAGE ERROR (Vaccine was stored in refrigerator on 04-Jun-2022 and administered vaccine on 21-Jul-2022).    No concomitant product use was reported.  Patient received half dose.  Vial did not undergone any temperature excursions.  No treatment information was provided
This spontaneous report has been received from a medical assistant referring to a patient of unknown age and gender. Information about concomitant medication, pertinent medical history and drug reactions/allergies was not provided. On 19-NOV-2018, the patient was vaccinated with improperly stored RECOMBIVAX HB (lot # R001084, expiration date 07-NOV-2020) for prophylaxis (strength, dose detail, anatomical location and route of administration were not reported). On 21-DEC-2018, the patient was vaccinated with improperly stored ROTATEQ (lot # R015435, expiration date 17-APR-2020) for prophylaxis (strength, dose detail, anatomical location and route of administration were not reported). No adverse effect was reported. The vaccines were exposed to temperature excursion between 0 degree Celsius (C) and 1 degree C for a time frame of 19 minutes and between 9 degree C and 25 degree C for 1 hour without previous temperature excursion. Data logger was involved. This is one of several reports received from the same reporter. Sender's Comments: US-009507513-1901USA001125.
Body aches, fatigue, fluxuating body temp Excessive sleep; 6 hours (day), 10 (night) Only lingering minor aches on 10/4/21, nothing after
pt. vax'd /w hepatitis B "years ago" & following vax pt experienced pain, swelling,& redness @ inject site.
Body aches and pains; tightness of chest; a slight mental fog; headache; slight fever; chills; This is a spontaneous report from a contactable consumer (patient). A 24-year-old female non-pregnant patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot number: EL3247), via an unspecified route of administration in arm left on 17Feb2021 at 13:15 (at the age of 24-year-old) as a dose 2, single for COVID-19 immunization. The patient's medical history was not reported. The patient's concomitant medications in two weeks included ethinylestradiol, levonorgestrel (LEVONORGESTREL AND ETHINYL ESTRADIOL), taken for birth control. Historical vaccine included BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot number: EL3247), via an unspecified route of administration in arm left on 27Jan2021 at 13:15 (at the age of 24-year-old) as a dose 1, single for COVID-19 immunization. It was reported that, the patient was not pregnant at time of vaccination. Other vaccine in four weeks was reported as no. No COVID prior vaccination and no COVID tested post vaccination. On 17Feb2021 at 21:00, around 8 hours after injection, the patient experienced body aches and pains developed along with chills, tightness of chest, a slight mental fog, headache and a slight fever. The reporter considered the events as non-serious. Treatment was not received for the events. On 17Feb2021, the patient underwent lab tests and procedures which included slight fever (body temperature), resulted as unknown results. The outcome of the events was recovered on an unspecified date in 2021.  Follow-up attempts completed. No further information expected.
Repeated vomiting; diarrhea; migraine headaches, sweating. Vomiting for 4 hours. Migraine for 48 hours. Symptoms all started approx 7 hours after vaccine.
Adverse effect of other vaccines and biological substances, initial encounter on 2022-12-10.
Localized arm pain within one hour, mild generalized muscle aches and dull headache for following 12 hours with increasing severe muscle aches, severe headache, dizziness, photophobia, fatigue, arm pain, shivering. 24 hours later after injection symptoms began to subside.
Patient stated that he had a red rash that extended from the top of his left arm to about the elbow. He said it was warm to the touch and painful. I recommended taking BENADRYL and oral pain relievers and also to use an ice pack if needed. Contacted patient again on 10/29/17 and he said the pain is going away and the rash is getting better.
client developed syncopal episode with 10 minutes following administration.  treatment was reclining, water offered, juice, granola bar.  VS taken and monitored for 30 minutes by EMS  recovered although remained pale and encouraged to seek PCP care if continues.
neck pain upon waking up the day after that was moderate/severe for 2-3 days, and continues to persist as mild neck pain at the time i am filling this out
is hurting really bad again; Couldn't sleep last night; Didn't feel well at all when receiving the second dose; Got a sore throat; Started to feel dizzy; Went to sleep right away; Had like a fever; woke up and had a very upset stomach; Throwing up; This is a spontaneous report from a contactable consumer. A 14-years-old male patient received Bsecond dose of NT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection. Batch/Lot number was not reported), dose 2 via an unspecified route of administration on 14Jun2021 as 2nd single dose for COVID-19 immunization. Medical history and concomitant medication were not reported. Patient's medical and concomitant medication history were not reported. Historical vaccine included 1st dose of BNT162B2 as a single dose for COVID-19 immunization. No reaction on previous exposure to drug. It was reported that, "patient reporting for received the second dose of the Pfizer Covid Vaccine yesterday, On 14Jun2021. Patient didn't feel well at all when receiving the second dose Pfizer Covid Vaccine. Patient had a sore throat and started to feel dizzy. Patient ate a burrito, a fatty food and patient went to sleep right away, had like a fever. When the patient woke up he had a very upset stomach. The patient couldn't really sleep last night. The patient woke up and took medicine. Woke up and had a very upset stomach and stomach was really hurting at 05:00 and patient threw up and right after throwing up felt better for like a minute. Hurting really bad again, patient was hurting more than yesterday. Patient ask what should do and if these symptoms are normal. The patient states, does not know what to do, but the patient fees really bad right now. Patient wanted to call his physician now. The caller states he can document his experience with Pfizer at a later time, right now the caller wants to get this done. The outcome of the event was unknown.  No further information provided. Follow up is excepted. Further information is requested.
Report of numbness of left arm, body aches, chills, nausea, HA, dry mouth, throat irritation .  Treatment:  one dose of Ibuprofen  Outcome: No improvement of symptoms, does not interfere with ADLs.
redness; swelling; received dose subcutaneously; This case was reported by a nurse via sales rep and described the occurrence of erythema in a 64-year-old female patient who received Herpes zoster (Shingrix) (batch number B257H, expiry date 26th June 2023) for prophylaxis.   On an unknown date, the patient received the 2nd dose of Shingrix (subcutaneous) .5 ml. On an unknown date, unknown after receiving Shingrix, the patient experienced erythema, swelling and intramuscular formulation administered by other route. On an unknown date, the outcome of the erythema, swelling and intramuscular formulation administered by other route were unknown.   It was unknown if the reporter considered the erythema and swelling to be related to Shingrix.     Additional Information: GSK Receipt Date: 10-May-2022 Reporter's comments: The patient received 2nd dose of Shingrix subcutaneously in left arm. The patient contacted the office with redness and swelling but did not seek medical attention. The patient just called to alert the office. Additional Supportive Information: The patients received second dose subcutaneously, which led to intramuscular formulation administered by other route.
Case number PHHY2012US051539 is an initial literature report received on 12 Jun 2012. Authors searched VAERS for reports of adverse events (AEs) in pregnant women who received INFLUENZA vaccine form 01 Jul 1999 through 30 Jun 2009. This case refers to a baby born (sex not specified) to mother (age not specified). The mother was vaccinated with INFLUENZA (manufacturer and batch number: unknown) at an unknown gestational age, on an unspecified date between 01 Jul 1999 through 30 Jun 2009 (see linked mother file: PHHY2012US051535). The fetus was exposed to this vaccine via transplacental route. On an unknown date at an unspecified gestational period, the baby was born with multiple deformities. The baby had multicystic renal dysplasia, atrial and ventricular septal defect and single umbilical artery. The causality was not reported. Authors stated that the VAERS system does not allow for active follow-up of adverse events among pregnant women; thus, pregnancy outcome data are not available for women who had an adverse pregnancy event. Authors concluded that no unusual patterns of pregnancy complications or fetal outcomes were observed in the VAERS reports of pregnant women after the administration of INFLUENZA.
I left you a voicemail also. I am just letting you know that I had the Booster this past Friday and I had a bad reaction on my left arm. Left arm was swollen , beet red, itchy and sore. I did put Ice and alcohol to calm the itch. Today seems somewhat better but still a little red. I Left a message with my PCP but no response. I just wanted to let you know so you are aware and to note on my file that I had this reaction
spots in mouth, swollen tongue, hands and feet. No rash, no fever, no site reaction
The injection site was sore much faster. By the next morning my upper arm started swelling and the muscle swelled so much my skin was tight. There was also muscle pain and the skin itched. Skin felt like it was going to bust open. It lasted about 6 days then was better each day until day 9 when it was back to normal.
3" x 6" erythema at injection site noted several hours after receipt of vaccine - lasted 3 days and no c/o pain or discomfort.
The patient received 2 doses of Shingrix vaccine with less than the minimum 2 month interval between doses. The doses were administered 31 days apart. No adverse events were reported.
NEUROPATHY ACUTE ST ELEVATION MI, UNSPECIFIED 3/6/2023  --  RECURRENCE OF HOSPITALIZATION WITH SAME SYMPTOMS
On 10/10/17 Patient reported Hives, Redness, Peeling, Itching and Sun Sensitivity lasting aprox. 1.5 weeks. Patient did not report using any medications to treat, but states it is now cleared up.
patient was fully vaccinated Pfizer 1/28/21 and 2/20/21  admitted to  Hospital 1/6/2022  patient died 1/15/2022 at 8:50AM  Received Death Abstract noting COVID -19 as 2ndary cause of death  for further information, contact care provider.
This spontaneous report was received from a nurse and refers to a patient of unknown age and gender. The patient's pertinent concurrent conditions, medical history and drug reactions or allergies, if any, were not provided. The nurse reported that, on 25-MAR-2019, the patient was inadvertently vaccinated with one dose of M-M-R II rHA (dose number, route and anatomical locations of administration were not provided; witch lot number either R008028 or R008031, both with expiration date on 18-MAR-2020) for prophylaxis. On an unspecified date, the dose of M-M-R II was exposed to a temperature excursion of -58 degrees Fahrenheit and +46 degrees Fahrenheit (46.4 degrees Fahrenheit) for a time frame of 6 minutes, which was detected by the Digital Data Logger. On an unspecified date, there was a previous temperature excursion of above 47 degrees Fahrenheit (47.7 degrees Fahrenheit) for 12 minutes. In addition, the nurse stated that M-M-R II was reconstituted with properly stored sterile diluent.  No adverse effects or product quality complaints were reported. This is one of several reports received from the same reporter. Sender's Comments: US-009507513-1903USA012691.
On 8/4/03 pt received IPV in right thigh. Complained of pain in his feet the next 2 nights. This AM 8/6/03 Mom noticed swelling of his leg. Exam today: moderate swelling of thigh and knee, right leg. No warmth, non tender. Ambulates with no problems. Dx: Local reaction.
Pt c/o abdominal pain, cramps and diarrhea 3 hours ofter taking vivotif. On day 1 and day 3 of schedule of taking vivotif. She took approximately at 11 AM and SS started by 2 PM. The SS lasted x6 hours.
Headache; Sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore arm) and HEADACHE (Headache) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 13-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 13-Feb-2021, the patient experienced PAIN IN EXTREMITY (Sore arm). On 17-Feb-2021, the patient experienced HEADACHE (Headache). At the time of the report, PAIN IN EXTREMITY (Sore arm) and HEADACHE (Headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were provided. No treatment information was provided.
she has Covid 19; she has Covid 19; cold; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. Other Case identifier(s): NVSC2022US016980_NS.  A 74-year-old female patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 3 (booster), single, (Batch/Lot number: unknown) as dose 2, single and (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: SUSPECTED COVID-19 (medically significant), DRUG INEFFECTIVE (medically significant), outcome "unknown" and all described as "she has Covid 19"; NASOPHARYNGITIS (medically significant), outcome "unknown", described as "cold".  Clinical information included: Patient advised she has Covid-19, is triple vaccinated, and feels like she has a cold.  The lot number for bnt162b2 was not provided and will be requested during follow up.
A week after my booster I suffered from severe migraines, nausea and chills. I developed hives and fatigued. A week later I went to the ER where they ran a few tests. They explained some kind of obstruction in my lungs. They gave me medication for my nausea.
Slight ringing in ears began after first vaccination.  After the second vaccination, the ringing in ears intensified to about an 8 out of 10.  This has now been going on for almost a week.
skin disease; This is a spontaneous report from a Pfizer-sponsored program. A non-contactable consumer (wife) reported that the husband (male) patient of an unspecified age received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE solution for injection, lot/batch number and expiration date not provided), via an unspecified route of administration on 21Jan2021 at SINGLE DOSE for COVID-19 immunization. Medical history and concomitant medications were not reported.  It was reported that yesterday (in Jan2021), her husband was prescribed with cefalexin (KEFLEX) for a skin disease not in relation to the vaccine for 4 times a day for 5 days straight. The wife asked it would be ok to take cefalexin on top of the COVID 19 vaccine. Outcome of the event was unknown.   No follow-up attempts are possible, information about lot/batch cannot be obtained.; Sender's Comments: The event skin disease is likely intercurrent and is unrelated to suspect drug BNT162B2.
he recently tested positive for the virus; he recently tested positive for the virus; he has is a head cold; This is a spontaneous report from a contactable consumer (patient) from a Pfizer-sponsored program. A male patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 2 via an unspecified route of administration on 08Feb2021 (Batch/Lot number was not reported) as single dose for covid-19 immunization. The patient's medical history and concomitant medications were not reported. The patient received series , last one was on 08Feb2021 and he recently (unspecified date) tested positive for the virus. The patient was asking how can that happen with the series on board. He stated all he has is a head cold. The outcome of the events was unknown.  Information on the lot/batch number has been requested.
GOT COVID-19 LESS THAN WEEK AFTER THE BOOSTER; This spontaneous report received from a patient via a company representative via social media concerned a female of unspecified age, race and ethnicity. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient was previously treated with covid-19 vaccine ad26. cov2. s (unspecified manufacturer) (suspension for injection, route of administration and batch number were not reported) dose was not reported, 1 total administered on unspecified day for prophylactic vaccination (Dose number in series 1). No adverse event reported following vaccination with covid-19 vaccine ad26.cov2.s. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of administration not reported, batch number and expiration date were unknown) dose was not reported, 1 total administered on an unspecified date for prophylactic vaccination  (Dose number in series 2). The batch number was not reported. The company is unable to perform follow up to request batch/lot number. No concomitant medications were reported.  On an unspecified date the patient experienced covid-19 less than week after the booster. The patient had a mild/moderate case (dose number in series 2). The patient reported she was not qualified for monoclonal antibody treatment and wore mask whenever she left the house.  The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of covid-19 was not reported. This report was non-serious. This case, from the same reporter is linked to 20211212699.